Key facts
- It has raised $62.3M; the latest was PE Growth/Expansion in Apr 2026.
- Notable investors include Yunfeng Capital, V-Capital, Shenzhen GTJA Investment Group, 6 Dimensions Capital, Fosun Pingyao — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Sinopharm Online
- ·The full record, as it builds
Funding rounds
No funding rounds for Sinopharm Online are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sinopharm Online
Operator of an online pharmaceutical distribution and healthcare service platform designed to facilitate compliant procurement, ordering, and delivery of medical and health-related products. The company offers digital ordering functions, licensed product catalog management, prescription handling support, cold chain and data integration with upstream suppliers, and service interfaces for downstream participants, enabling pharmacies, clinics, medical institutions, and individual consumers to manage transactions efficiently across the healthcare distribution chain.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shanghai, China
- Founded
- 2004
- Employees
- 11
- Website
- yao123.cn/
- Ownership
- Privately Held (backing)
Sinopharm Online doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sinopharm Online shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sinopharm Online in its N-PORT filings yet. We sweep new filings monthly.